Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GELFAND

Showing results (841-850 of 889) with videos related to

Pageof 89
Sort By:
Journal of the American Academy of Dermatology|August 3, 2019
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension studyMette Deleuran, Diamant Thaçi, Lisa A Beck, et al.
JCI Insight|October 26, 2020
Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over timeAparna Sajja, Khaled M Abdelrahman, Aarthi S Reddy, et al.
Science Translational Medicine|April 14, 2017
Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosisMichael E Ward, Robert Chen, Hsin-Yi Huang, et al.
Annals of Neurology|June 24, 2025
High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple SclerosisSimone Sacco, Nico Papinutto, Vinicius A Schoeps, et al.
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology|September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
The Journal of Investigative Dermatology|July 22, 2021
Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational StudiesAlvaro Gonzalez-Cantero, Meron Teklu, Alexander V Sorokin, et al.
Annals of Neurology|March 10, 2019
Silent progression in disease activity-free relapsing multiple sclerosis, Bruce A C Cree, Jill A Hollenbach, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Archives of Dermatology|January 18, 2012
Consensus guidelines for the management of plaque psoriasisSylvia Hsu, Kim Alexander Papp, Mark G Lebwohl, et al.
Pageof 89

Showing results (841-850 of 889) with videos related to

Sort By:
Pageof 89
Journal of the American Academy of Dermatology|August 3, 2019
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension studyMette Deleuran, Diamant Thaçi, Lisa A Beck, et al.
JCI Insight|October 26, 2020
Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over timeAparna Sajja, Khaled M Abdelrahman, Aarthi S Reddy, et al.
Science Translational Medicine|April 14, 2017
Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosisMichael E Ward, Robert Chen, Hsin-Yi Huang, et al.
Annals of Neurology|June 24, 2025
High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple SclerosisSimone Sacco, Nico Papinutto, Vinicius A Schoeps, et al.
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology|September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
The Journal of Investigative Dermatology|July 22, 2021
Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational StudiesAlvaro Gonzalez-Cantero, Meron Teklu, Alexander V Sorokin, et al.
Annals of Neurology|March 10, 2019
Silent progression in disease activity-free relapsing multiple sclerosis, Bruce A C Cree, Jill A Hollenbach, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Archives of Dermatology|January 18, 2012
Consensus guidelines for the management of plaque psoriasisSylvia Hsu, Kim Alexander Papp, Mark G Lebwohl, et al.
Pageof 89